Literature DB >> 14502802

Predicting tumor volume in radical prostatectomy specimens from patients with prostate cancer.

Lori E Eichelberger1, Michael O Koch, Joanne K Daggy, Thomas M Ulbright, John N Eble, Liang Cheng.   

Abstract

Tumor volume has prognostic value in numerous malignant neoplasms; however, the determination of tumor volume in prostatic adenocarcinoma remains problematic. We tested the hypothesis that the diameter of the largest focus of carcinoma in whole-mount prostate sections predicts the volume of adenocarcinoma in the entire prostate. We evaluated 184 radical prostatectomy specimens by whole-mount processing of the entire prostate. The maximum diameter of the largest focus of carcinoma was measured directly on glass slides. Tumor volume in the entire prostate was calculated by the grid method. The maximum tumor diameter ranged from 0.1 to 4.1 cm (median, 1.6 cm). The total tumor volume ranged from 0.1 to 12.5 cm3 (median, 1.6 cm3). There were significant correlations between maximum tumor diameter and tumor volume (Spearman correlation coefficient = 0.84; P < .0001), surgical margin status (P < .001), perineural invasion (P < .001), serum prostate-specific antigen level at diagnosis (P = .004), Gleason score (P = .004), and pathologic stage (P < .0001). Maximum tumor diameter is a predictor of tumor volume and might be useful for the assessment of tumor volume in routinely processed prostatectomy specimens.

Entities:  

Mesh:

Year:  2003        PMID: 14502802     DOI: 10.1309/82U1-089X-LQGK-MMN1

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  14 in total

1.  Predicting the risk of non-organ-confined prostate cancer when perineural invasion is found on biopsy.

Authors:  Michael A Gorin; Heather J Chalfin; Jonathan I Epstein; Zhaoyong Feng; Alan W Partin; Bruce J Trock
Journal:  Urology       Date:  2014-03-19       Impact factor: 2.649

2.  The influence of extent of surgical margin positivity on prostate specific antigen recurrence.

Authors:  R E Emerson; M O Koch; T D Jones; J K Daggy; B E Juliar; L Cheng
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

3.  Total intraglandular and index tumor volumes predict biochemical recurrence in prostate cancer.

Authors:  Su-Jin Shin; Cheol Keun Park; Sung Yoon Park; Won Sik Jang; Joo Yong Lee; Young Deuk Choi; Nam Hoon Cho
Journal:  Virchows Arch       Date:  2016-06-15       Impact factor: 4.064

4.  The presence of benign prostatic glandular tissue at surgical margins does not predict PSA recurrence.

Authors:  K M Kernek; M O Koch; J K Daggy; B E Juliar; L Cheng
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

5.  Dynamic contrast-enhanced magnetic resonance imaging for risk stratification in patients with prostate cancer.

Authors:  Hyungin Park; Seung Ho Kim; Joo Yeon Kim
Journal:  Quant Imaging Med Surg       Date:  2022-01

6.  New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effect.

Authors:  Yucel Altundal; Gizem Cifter; Alexandre Detappe; Erno Sajo; Panagiotis Tsiamas; Piotr Zygmanski; Ross Berbeco; Robert A Cormack; Mike Makrigiorgos; Wilfred Ngwa
Journal:  Phys Med       Date:  2014-12-06       Impact factor: 2.685

7.  Incidentally found prostate cancer and influence on overall survival after radical cystoprostatectomy.

Authors:  Algimantas Sruogis; Albertas Ulys; Giedre Smailyte; Zygimantas Kardelis; Arunas Kulboka; Giedre Anglickienė; Nerimantas Samalavicius; Marius Anglickis
Journal:  Prostate Cancer       Date:  2012-06-03

Review 8.  Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment.

Authors:  M R Da Rosa; J Trachtenberg; R Chopra; M A Haider
Journal:  Cancer Imaging       Date:  2011-10-03       Impact factor: 3.909

9.  Cancer core length from targeted biopsy: an index of prostate cancer volume and pathological stage.

Authors:  Demetrios N Simopoulos; Anthony E Sisk; Alan Priester; Ely R Felker; Lorna Kwan; Merdie K Delfin; Robert E Reiter; Leonard S Marks
Journal:  BJU Int       Date:  2019-02-24       Impact factor: 5.969

10.  Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer.

Authors:  I M van Oort; J A Witjes; D E G Kok; L A L M Kiemeney; C A Hulsbergen-vandeKaa
Journal:  World J Urol       Date:  2008-02-12       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.